3-Fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACVRNL683
CAS No. :
1356483-70-9
Molecular Formula :
C12H17BFNO2
Molecular Weight :
237.08

IUPAC Name:3-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

3-Fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$304.00Login to see priceInquiryInquiry
100mg98%$445.00Login to see priceInquiryInquiry
250mg98%$627.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name3-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD18712609
Molecular FormulaC12H17BFNO2
Molecular Weight237.08
SMILESCC1=C(B2OC(C)(C)C(C)(C)O2)C=NC=C1F
InChI KeyPILYRFHMMPSECJ-UHFFFAOYSA-N
Synonym5-Fluoro-4-picoline-3-boronic acid pinacol ester;3-Fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;Pyridine, 3-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1356483-70-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVRNL683 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACKVDL921 route compound structure diagram
    ACKVDL9211211517-76-8 In Stock
  4. Then
  5. ACVRNL683 route product structure diagram
    ACVRNL6831356483-70-9
Inquiry

2. ACVRNL683 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVRNL683 route product structure diagram
    ACVRNL6831356483-70-9
Inquiry

Comments (0)